GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Todos Medical Ltd (OTCPK:TOMDF) » Definitions » Cash Flow from Financing

Todos Medical (Todos Medical) Cash Flow from Financing : $7.04 Mil (TTM As of Sep. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Todos Medical Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2022, Todos Medical paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.69 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.50 Mil on other financial activities. In all, Todos Medical earned $1.19 Mil on financial activities for the three months ended in Sep. 2022.


Todos Medical Cash Flow from Financing Historical Data

The historical data trend for Todos Medical's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Todos Medical Cash Flow from Financing Chart

Todos Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cash Flow from Financing
Get a 7-Day Free Trial 1.16 0.45 1.67 7.09 15.18

Todos Medical Quarterly Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.75 3.49 1.39 0.96 1.19

Todos Medical Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Todos Medical's Cash from Financing for the fiscal year that ended in Dec. 2021 is calculated as:

Todos Medical's Cash from Financing for the quarter that ended in Sep. 2022 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Todos Medical  (OTCPK:TOMDF) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Todos Medical's issuance of stock for the three months ended in Sep. 2022 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Todos Medical's repurchase of stock for the three months ended in Sep. 2022 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Todos Medical's net issuance of debt for the three months ended in Sep. 2022 was $0.69 Mil. Todos Medical received $0.69 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Todos Medical's net issuance of preferred for the three months ended in Sep. 2022 was $0.00 Mil. Todos Medical paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Todos Medical's cash flow for dividends for the three months ended in Sep. 2022 was $0.00 Mil. Todos Medical received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Todos Medical's other financing for the three months ended in Sep. 2022 was $0.50 Mil. Todos Medical received $0.50 Mil on other financial activities.


Todos Medical Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Todos Medical's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Todos Medical (Todos Medical) Business Description

Traded in Other Exchanges
N/A
Address
121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.
Executives
Gerald Commissiong director, officer: CEO and Director 675 ALMANOR AVENUE, SUNNYVALE CA 94085
Strategic Investment Holdings, Llc 10 percent owner 875 CARRETERA 693, SUITE 201, DORADO PR 00646

Todos Medical (Todos Medical) Headlines

From GuruFocus

Todos Medical Announces BioFuture� NYC 2022 Presentation

By Value_Insider Value_Insider 11-04-2022